203 related articles for article (PubMed ID: 22739256)
1. Cost-effectiveness of intensity-modulated radiotherapy in oropharyngeal cancer.
Yong JH; Beca J; O'Sullivan B; Huang SH; McGowan T; Warde P; Hoch JS
Clin Oncol (R Coll Radiol); 2012 Sep; 24(7):532-8. PubMed ID: 22739256
[TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness of intensity-modulated radiotherapy in prostate cancer.
Yong JH; Beca J; McGowan T; Bremner KE; Warde P; Hoch JS
Clin Oncol (R Coll Radiol); 2012 Sep; 24(7):521-31. PubMed ID: 22705100
[TBL] [Abstract][Full Text] [Related]
3. Toxicity and cost-effectiveness analysis of intensity modulated radiation therapy versus 3-dimensional conformal radiation therapy for postoperative treatment of gynecologic cancers.
Chen LA; Kim J; Boucher K; Terakedis B; Williams B; Nickman NA; Gaffney DK
Gynecol Oncol; 2015 Mar; 136(3):521-8. PubMed ID: 25562668
[TBL] [Abstract][Full Text] [Related]
4. Protons in head-and-neck cancer: bridging the gap of evidence.
Ramaekers BL; Grutters JP; Pijls-Johannesma M; Lambin P; Joore MA; Langendijk JA
Int J Radiat Oncol Biol Phys; 2013 Apr; 85(5):1282-8. PubMed ID: 23273998
[TBL] [Abstract][Full Text] [Related]
5. A decision model to estimate the cost-effectiveness of intensity modulated radiation therapy (IMRT) compared to three dimensional conformal radiation therapy (3DCRT) in patients receiving radiotherapy to the prostate bed.
Carter HE; Martin A; Schofield D; Duchesne G; Haworth A; Hornby C; Sidhom M; Jackson M
Radiother Oncol; 2014 Aug; 112(2):187-93. PubMed ID: 24929702
[TBL] [Abstract][Full Text] [Related]
6. Using decision analysis to determine the cost-effectiveness of intensity-modulated radiation therapy in the treatment of intermediate risk prostate cancer.
Konski A; Watkins-Bruner D; Feigenberg S; Hanlon A; Kulkarni S; Beck JR; Horwitz EM; Pollack A
Int J Radiat Oncol Biol Phys; 2006 Oct; 66(2):408-15. PubMed ID: 16887291
[TBL] [Abstract][Full Text] [Related]
7. Making a case for high-volume robotic surgery centers: A cost-effectiveness analysis of transoral robotic surgery.
Rudmik L; An W; Livingstone D; Matthews W; Seikaly H; Scrimger R; Marshall D
J Surg Oncol; 2015 Aug; 112(2):155-63. PubMed ID: 26171771
[TBL] [Abstract][Full Text] [Related]
8. Intensity-modulated radiation therapy (IMRT) versus 3-dimensional conformal radiation therapy (3D-CRT) for head and neck cancer: cost-effectiveness analysis.
Marta GN; Weltman E; Ferrigno R
Rev Assoc Med Bras (1992); 2018 Apr; 64(4):318-323. PubMed ID: 30133610
[TBL] [Abstract][Full Text] [Related]
9. Upfront treatment of locally advanced cervical cancer with intensity modulated radiation therapy compared to four-field radiation therapy: a cost-effectiveness analysis.
Lesnock JL; Farris C; Beriwal S; Krivak TC
Gynecol Oncol; 2013 Jun; 129(3):574-9. PubMed ID: 23500086
[TBL] [Abstract][Full Text] [Related]
10. A model of the cost-effectiveness of intensity-modulated radiotherapy in comparison with three-dimensional conformal radiotherapy for the treatment of localised prostate cancer.
Hummel SR; Stevenson MD; Simpson EL; Staffurth J
Clin Oncol (R Coll Radiol); 2012 Dec; 24(10):e159-67. PubMed ID: 23040143
[TBL] [Abstract][Full Text] [Related]
11. Toxicity and outcome of intensity-modulated radiotherapy versus 3-dimensional conformal radiotherapy for oropharyngeal cancer: a matched-pair analysis.
Al-Mamgani A; Van Rooij P; Tans L; Teguh DN; Levendag PC
Technol Cancer Res Treat; 2013 Apr; 12(2):123-30. PubMed ID: 23098281
[TBL] [Abstract][Full Text] [Related]
12. Intensity-modulated radiotherapy versus conventional and 3D conformal radiotherapy in patients with head and neck cancer: is there a worthwhile quality of life gain?
Tribius S; Bergelt C
Cancer Treat Rev; 2011 Nov; 37(7):511-9. PubMed ID: 21324605
[TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness analysis of intensity modulated radiation therapy versus 3-dimensional conformal radiation therapy for anal cancer.
Hodges JC; Beg MS; Das P; Meyer J
Int J Radiat Oncol Biol Phys; 2014 Jul; 89(4):773-83. PubMed ID: 24726392
[TBL] [Abstract][Full Text] [Related]
14. Cost-Effectiveness Analysis of Intensity Modulated Radiation Therapy Versus 3-Dimensional Conformal Radiation Therapy for Preoperative Treatment of Extremity Soft Tissue Sarcomas.
Richard P; Phillips M; Smith W; Davidson D; Kim E; Kane G
Int J Radiat Oncol Biol Phys; 2016 Jul; 95(3):999-1008. PubMed ID: 27130792
[TBL] [Abstract][Full Text] [Related]
15. Two-year and lifetime cost-effectiveness of intensity modulated radiation therapy versus 3-dimensional conformal radiation therapy for head-and-neck cancer.
Kohler RE; Sheets NC; Wheeler SB; Nutting C; Hall E; Chera BS
Int J Radiat Oncol Biol Phys; 2013 Nov; 87(4):683-9. PubMed ID: 24138916
[TBL] [Abstract][Full Text] [Related]
16. Cost-Effectiveness Analysis of Intensity Modulated Radiation Therapy Versus Proton Therapy for Oropharyngeal Squamous Cell Carcinoma.
Sher DJ; Tishler RB; Pham NL; Punglia RS
Int J Radiat Oncol Biol Phys; 2018 Jul; 101(4):875-882. PubMed ID: 29976499
[TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness analysis of intensity-modulated radiation therapy with normal and hypofractionated schemes for the treatment of localised prostate cancer.
Zemplényi AT; Kaló Z; Kovács G; Farkas R; Beöthe T; Bányai D; Sebestyén Z; Endrei D; Boncz I; Mangel L
Eur J Cancer Care (Engl); 2018 Jan; 27(1):. PubMed ID: 26782759
[TBL] [Abstract][Full Text] [Related]
18. Intensity-modulated radiotherapy for the treatment of prostate cancer: a systematic review and economic evaluation.
Hummel S; Simpson EL; Hemingway P; Stevenson MD; Rees A
Health Technol Assess; 2010 Oct; 14(47):1-108, iii-iv. PubMed ID: 21029717
[TBL] [Abstract][Full Text] [Related]
19. Prospective functional outcomes in sequential population based cohorts of stage III/ IV oropharyngeal carcinoma patients treated with 3D conformal vs. intensity modulated radiotherapy.
Kerr P; Myers CL; Butler J; Alessa M; Lambert P; Cooke AL
J Otolaryngol Head Neck Surg; 2015 May; 44(1):17. PubMed ID: 25964113
[TBL] [Abstract][Full Text] [Related]
20. The impact of treatment modality and radiation technique on outcomes and toxicity of patients with locally advanced oropharyngeal cancer.
Al-Mamgani A; van Rooij P; Verduijn GM; Mehilal R; Kerrebijn JD; Levendag PC
Laryngoscope; 2013 Feb; 123(2):386-93. PubMed ID: 23404489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]